EUVIMEDEUVIMED entdecken
Crossref

Photosensitive smart hydrogel loaded Neratinib for NIR-triggered photodynamic treatment for improved chemotherapy in breast cancers: In vitro and In vivo analysis

Dalin Xiang, Zheng Nie

Journal of Pharmaceutical Sciences · 2026-01 · 115 (1) · 104016

DOI: 10.1016/j.xphs.2025.104016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Sciences, 2026-01. Verfasst von Dalin Xiang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, the First People's Hospital of Jingzhou, Jingzhou 434000, Hubei Province, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Hydrogels, Photochemotherapy, Quinolines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC), the most common malignancy in women, is increasing in prevalence, and most treatment modalities frequently involve considerable adverse consequences. The research intends to synthesize a hydrogel incorporating MHBC, PIPAM, AZO, and NB. The hydrogel was synthesized using the radical polymerization process. The AZO group rendered the hydrogel photodynamically effective. The hydrogel demonstrated robust near-infrared (NIR) activated and prolonged drug delivery efficacy. In vitro assays on MDA-MB-231 and MCF-7 cells indicated that M/PP/A/NB significantly decreased cell viability, especially with NIR activation. It also diminished AO/EB staining, ROS levels, and DAPI signals. NB inhibits phosphorylation of HER2 and EGFR by targeting ATP-binding sites in tyrosine kinase domains, interrupting MAPK signaling and triggering cell death, as shown by RT-PCR. The in vivo investigation in a mouse model demonstrated the efficacy of hydrogel in treating BC, demonstrated by a decrease in tumor volume. The hydrogel addresses the BC without impacting any organs. Research will strengthen the hydrogel's responsiveness to NIR light, stability, biodegradability, and cancer-type alteration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHydrogelsPhotochemotherapyQuinolinesPhotosensitizing AgentsAntineoplastic AgentsHumansAnimalsFemaleMiceMCF-7 CellsCell Line, TumorCell SurvivalInfrared RaysErb-b2 Receptor Tyrosine KinasesErbB ReceptorsMice, NudeMice, Inbred BALB CXenograft Model Antitumor Assays

Stichwörter der Autor:innen

Breast cancerHydrogelNIRPhotodynamic therapyPhotosensitive

Substanzen

HydrogelsQuinolinesPhotosensitizing AgentsAntineoplastic AgentsErb-b2 Receptor Tyrosine KinasesErbB ReceptorsneratinibERBB2 protein, human

Autor:innen und Institutionen

  • Department of Breast Surgery, the First People's Hospital of Jingzhou, Jingzhou 434000, Hubei Province, China.
  • Department of Breast Surgery, the First People's Hospital of Jingzhou, Jingzhou 434000, Hubei Province, China. Electronic address: ZhengNie89@hotmail.com.

Zitieren

APA

Xiang, D., & Nie, Z. (2026). Photosensitive smart hydrogel loaded Neratinib for NIR-triggered photodynamic treatment for improved chemotherapy in breast cancers: In vitro and In vivo analysis. Journal of Pharmaceutical Sciences, 115(1), 104016. https://doi.org/10.1016/j.xphs.2025.104016

Vancouver

Xiang D, Nie Z. Photosensitive smart hydrogel loaded Neratinib for NIR-triggered photodynamic treatment for improved chemotherapy in breast cancers: In vitro and In vivo analysis. Journal of Pharmaceutical Sciences. 2026;115(1):104016. doi:10.1016/j.xphs.2025.104016

BibTeX
@article{Xiang2026,
  author = {Xiang, Dalin and Nie, Zheng},
  title = {Photosensitive smart hydrogel loaded Neratinib for NIR-triggered photodynamic treatment for improved chemotherapy in breast cancers: In vitro and In vivo analysis},
  journal = {Journal of Pharmaceutical Sciences},
  year = {2026},
  volume = {115},
  number = {1},
  pages = {104016},
  doi = {10.1016/j.xphs.2025.104016}
}
Kostenlos starten →